T. Cardillo

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials

Eric L. Simpson, J.‐P. Lacour, Lynda Spelman et al. · British Journal of Dermatology · 2020 · 379 citations

Medicine, Dermatology, Pharmacology +13

OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study

M. C. Genovese, Joel M. Kremer, Omid Zamani et al. · Annals of the Rheumatic Diseases · 2015 · 27 citations

Medicine, Pharmacology, Pharmacotherapy +14

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

Thomas Werfel, Alan D. Irvine, Christine Bangert et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 17 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis

Josef S Smolen, Mark C. Genovese, Tohru Takeuchi et al. · Annals of the Rheumatic Diseases · 2016 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +14